FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine Recall

PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center · West Columbia, SC

Risk level
Class II
Reported by FDA
Oct 30, 2019
Recall ID
D-0148-2020
Check your lot numberHow we source this data

Summary

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center recalled PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine starting Oct 9, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0148-2020 on Oct 30, 2019. Reason: GMP Deviations: potential glass contamination. Status: Terminated.

Why it was recalled

GMP Deviations: potential glass contamination

Product description

PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL, Rx Only Total Dose: (500 mcg/312.5 mg)/250 mL, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-530-25

Lot numbers, UPCs & expiration codes

Lots: FB9014A Exp. 12/09/2019; FB9017A Exp. 12/16/2019

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0148-2020
Classification
Class II
Status
Terminated
Recall initiated
Oct 9, 2019
FDA report date
Oct 30, 2019
Quantity
1370 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center

Original FDA data

Every field from FDA enforcement report D-0148-2020, exactly as published.

Show all FDA fields
City
West Columbia
State
SC
Status
Terminated
Country
United States
Event ID
84000
Address
4500 12th Street Ext
Code information
Lots: FB9014A Exp. 12/09/2019; FB9017A Exp. 12/16/2019
Postal code
29172-3025
Report date
Oct 30, 2019
Product type
Drugs
Recall number
D-0148-2020
Classification
Class II
Recalling firm
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
Product quantity
1370 bags
Termination date
Dec 1, 2020
Reason for recall
GMP Deviations: potential glass contamination
Voluntary / mandated
Voluntary: Firm initiated
Product description
PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL, Rx Only Total Dose: (500 mcg/312.5 mg)/250 mL, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-530-25
Distribution pattern
Nationwide.
Recall initiation date
Oct 9, 2019
Initial firm notification
Letter
Center classification date
Oct 18, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0148-2020, published Oct 30, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls